Glucose analogues in the chemotherapy of herpesvirus infections

Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.

Virology·1997

Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.

Antiviral research·1995

Introduction: are aging and space effects similar?

Experimental gerontology·1991

Inhibition of herpesvirus-induced thymidine kinase and DNA polymerase by beta-hydroxynorvaline.

FEBS letters·1987

Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.

Biochemical and biophysical research communications·1986

Efficacy of glycoprotein inhibitors alone and in combination with trifluridine in the treatment of murine herpetic keratitis.

Current eye research·1986

Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap.

Pharmacology & therapeutics·2026

The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases.

Pharmacology & therapeutics·2026

The rhythm of pressure: Circadian disruption and chronotherapy.

Pharmacology & therapeutics·2026

Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies.

Pharmacology & therapeutics·2026

Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization.

Pharmacology & therapeutics·2026

Galectin-3 and its inhibitors: Overview and perspectives.

Pharmacology & therapeutics·2026

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Environmental health perspectives·2026

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Frontiers in pharmacology·2026

Screening Bacteriuria Using the Sysmex UF-5000 during Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer.

Chonnam medical journal·2026

Cannabis use and perceptions among rural and urban cancer patients and survivors from a Pennsylvania cancer center.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Selective cognitive changes in a multidrug mouse model of chemotherapy-induced adverse effects.

Brain research·2026

Related Experiment Videos

Glucose analogues in the chemotherapy of herpesvirus infections

Related Concept Videos

Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.

Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.

Introduction: are aging and space effects similar?

Inhibition of herpesvirus-induced thymidine kinase and DNA polymerase by beta-hydroxynorvaline.

Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.

Efficacy of glycoprotein inhibitors alone and in combination with trifluridine in the treatment of murine herpetic keratitis.

Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap.

The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases.

The rhythm of pressure: Circadian disruption and chronotherapy.

Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies.

Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization.

Galectin-3 and its inhibitors: Overview and perspectives.

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Screening Bacteriuria Using the Sysmex UF-5000 during Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer.

Cannabis use and perceptions among rural and urban cancer patients and survivors from a Pennsylvania cancer center.

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

Selective cognitive changes in a multidrug mouse model of chemotherapy-induced adverse effects.

Related Experiment Videos

Glucose analogues in the chemotherapy of herpesvirus infections

Related Concept Videos

Related Articles